For the quarter ended December 2023, Thermo Fisher Scientific (TMO) reported revenue of $10.89 billion, down 4.9% over the same period last year. EPS came in at $5.67, compared to $5.40 in the year-ago quarter.The reported revenue represents a surprise of +1.40% over the Zacks Consensus Estimate of $10.74 billion. With the consensus EPS estimate being $5.64, the EPS surprise was +0.53%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...